Weekly Tech+Bio Highlights #78: AI Agents Rush In
Roche and Lilly scale up pharma's biggest AI supercomputers, a billion-dollar startup unveils its virtual cell, ex-GSK AI leaders launch startup, and agents are everywhere
Everyone seems to be building agents right now. In what looks akin to be the next “gold rush,” tech stacks are being rebuilt around them, open-source AI assistants are gaining traction fast, and major companies are pouring billions into autonomous systems while trimming headcount.
GTC 2026 brought that energy straight into life sciences. NVIDIA CEO Jense…